Inhibition of human platelet aggregation using AIIB derived peptides that maintain AIIBB3 in its low affinity state von Trypou, P, Lee, W.H, Schaffner-Reckinger, E, Tsoukatos, D.C, Aylward, K, Moussis, V, Tsikaris, V, Malisiova, E, Gkourogianni, A, Papadaki, S, Egot, M, Baruch, D, Kieffer, N, Bachelot-Loza, C

Volltext

Highly constrained cyclic (S,S) ‐CXaaC‐ peptides as inhibitors of fibrinogen binding to platelets von KOUKI, A., MITSIOS, J. V., SAKARELLOS‐DAITSIOTIS, M., SAKARELLOS, C., TSELEPIS, A. D., TSIKARIS, V., TSOUKATOS, D. C.

Volltext

Mechanisms of PAF formation upon coppercatalyzed oxidation of human LDL von Tsoukatos, D.C., Liapikos, T.A., Tselepis, A.D., Chapman, M.J., Ninio, E.

Volltext

Involvement of phospholipids on apolipoprotein B modification during low density lipoprotein oxidation von Tsoukatos, D.C., Karakatsani, A.I., Liapikos, T.A., Troganis, A.N.

Volltext

PLATELET-ACTIVATING FACTOR (PAF) BIOACTIVITY FORMATION AND LYSO-PAF ACCUMULATION IN HUMAN ARTERIES von Tsoukatos, D.C., Moussis, V., Panopoulou, C.P., Christofidou, E.D., Koussissis, S., Brocheriou, I., Ninio, E., Sismanidis, S., Siminelakis, S.

Volltext

PO10-276 THE ROLE OF PAF-ACETYLHYDROLASE IN THE DEVELOPMENT OF ATHEROSCLEROSIS von Tsoukatos, D.C., Moussis, V., Panopoulou, C.P., Christofidou, E.D., Koussisis, S., Brocheriou, I., Ninio, E., Sismanidis, S., Siminelakis, S.

Volltext